Accenture shares jump 20% in pre-market as Q4 earnings, 2027 outlook beat estimates

Evommune presents Phase 2a atopic dermatitis trial data

Investing.com · News 11m ago

Copart extends tender offer for ACV Auctions to October 7

Investing.com · News 11m ago

Aktis Oncology initiates phase 1b trial for lung cancer drug

Investing.com · News 11m ago

Pasqal appoints Florence Lao as chief legal officer

Investing.com · News 11m ago

Airgain appoints Stephan Memmen to board of directors

Investing.com · News 11m ago

Azitra advances skin rash treatment trial to second cohort

Investing.com · News 11m ago

NANO Nuclear signs deal to acquire NRC-licensed fuel facility

Investing.com · News 11m ago

Corteva completes spin-off of seed business unit

Investing.com · News 11m ago

Next Technology approves $35M R&D budget through March 2027

Investing.com · News 11m ago

U.S. Bond Yields Hit Highest Level Since 2002

The New York Times · Business 13m ago